Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the deadliest malignancies worldwide due to the lack of effective treatments. Chemoprevention in high-risk patients is a promising, alternative strategy. In this study, pioglitazone was investigated for its ability to prevent hepatocarcinogenesis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Gastrointest Surg
Main Authors: Li, Shen, Ghoshal, Sarani, Sojoodi, Mozhdeh, Arora, Gunisha, Masia, Ricard, Erstad, Derek J., Lanuti, Michael, Hoshida, Yujin, Baumert, Thomas F., Tanabe, Kenneth K., Fuchs, Bryan C.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2018
Assuntos:
2018 SSAT Plenary Presentation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6328630/
https://ncbi.nlm.nih.gov/pubmed/30367397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11605-018-4004-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados